FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely to infectious diseases, and can be used for treating whooping cough and/or for Bordetella infection protection. Polypeptide under the invention represents a fragment of adenylate cyclase Bordetella containing CD11b/CD18 interaction domain from an amino acid sequence extended from position 1166 to position 1281 SEQ ID NO:1. Said invention also concerns the specific fragments of adenylate cyclase Bordetella containing CD11b/CD18 interaction domain, and to their application, particularly for targeting of molecules of interest to CD11b expressing cells.
EFFECT: use of the inventions allows extending the range of products for treatment and prevention of the Bordetella infection.
26 cl, 9 dwg
| Title |
Year |
Author |
Number |
| VECTORS FOR DELIVERY OF MOLECULES TO CD11b-EXPRESSING CELLS |
2001 |
- Leklerk Klod
- Germonpre P'Er
- Ladan Daniel'
- Gjuizo Nikol'
- Kelef Nadija
- Bosh Sesil'
- Fajoll' Katrin
- Ehl'-Azami Ehl'-Idrissi Mokhammed
|
RU2312143C2 |
| MUTANT POLYPEPTIDES SUAA AND POLYPEPTIDE DERIVATIVES SUITABLE FOR DELIVERY OF IMMUNOGENIC MOLECULES IN CELL |
2010 |
- Sebo Peter
- Ositskova Adriana
- Masin Irzhi
- Fajol Katrin
- Krusek Yan
- Basler Marek
- Leklerk Klod
- Ositska Radim
|
RU2585216C2 |
| RECOMBINANT PROTEIN CARRYING HUMAN PAPILLOMA VIRUS EPITOPES, PROTEIN EMBEDDED ADENYLATECYCLASE OR ITS FRAGMENT, ITS THERAPEUTIC APPLICATION |
2005 |
- Preville Khav'Er-Ehdmond-Ehduard
- Leklerk Klod
- Ladant Daniel
- Timmerman Benedikt
|
RU2441022C2 |
| CyaA-CARRIED POLYPEPTIDE (VERSIONS) AND USE TO INDUCE BOTH THERAPEUTIC AND PROPHYLACTIC IMMUNE RESPONSES |
2012 |
- Eskerr Mishel
- Momo Mari
- Guber Ann
- Misseri Jolanda
|
RU2668795C2 |
| COMPOSITIONS CAUSING SPECIFIC RESPONSE OF CYTOTOXIC T-LYMPHOCYTES, INCLUDING LYMPH-ABLATIVE COMPOUND AND MOLECULE WHICH CONTAINS ANTIGEN SEQUENCES AND IS TARGETED AT SPECIALISED ANTIGEN-PRESENTING CELLS |
2007 |
- Previll' Ksav'E
- Timmerman Benedikt
|
RU2448729C2 |
| AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA |
2006 |
- Lekler Klod
- Lasarte-Sagastibel'Sa Khuan-Khose
- Gorrais-Ajala Marta
- Prieto-Val'Tuehn'Ja Khesus
|
RU2430738C2 |
| CD3-EPSILON-BINDING DOMAIN HAVING INTERSPECIES SPECIFICITY |
2008 |
- Klinger,Matthias
- Raum,Tobias
- Rau,Doris
- Mangold,Susanne
- Kischel,Roman
- Lutterbuse,Ralf
- Hoffmann,Patrick
- Kufer,Peter
|
RU2561457C2 |
| HYBRIDOMA DESIGNATES AS 199M AND MONOCLONAL ANTIBODY SECRETED BY THIS HYBRIDOMA |
1997 |
- Gehllatin Uil'Jam M.
- Vehn Der Viren Monika
|
RU2183671C2 |
| POLYNUCLEOTIDE SEQUENCE CODING STRUCTURED PERTACTIN PROTEIN; VECTOR INCLUDING SUCH SEQUENCE; AND VACCINE COMPOSITIONS CONTAINING PERTACTIN PROTEIN OR VECTOR |
2008 |
- Kintana Vaskes Diokhenes
- Menendes Medina Tamara
- Al'Vares Akosta Anabel'
- Krus Leal Joehlis
- Gil'En N'Eto Kherardo Ehnrike
|
RU2499046C2 |
| CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND TNFα ANTAGONIST DOMAIN |
2015 |
- Shofild Daren
- Sliman Mettyu Aleksander
- Chessell Ien Patrik
- Khatcher Dzhonatan
- Lou Devid
|
RU2678810C2 |
